Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial)
Clinical trial NCT04450654 · WITHDRAWN
Trial details
- NCT number
- NCT04450654
- Sponsor
- University of Washington
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2022-07-25
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.